News & Updates
Filter by Specialty:
Ribociclib plus endocrine therapy: A win for early breast cancer?
In the second interim efficacy analysis of the phase III NATALEE trial, a combination regimen comprising the CDK4/6 inhibitor ribociclib and endocrine therapy (ET) demonstrated favourable signals for the adjuvant treatment of stage II/III hormone receptor-positive, HER2-negative (HR+, HER2–) early breast cancer.
Ribociclib plus endocrine therapy: A win for early breast cancer?
16 Jun 2023
Home BP a better measure of CVD risk than office BP, says study
In middle-aged adults, masked hypertension is associated with several markers of cardiovascular disease (CVD), which suggests that home blood pressure (BP) may be a better predictor of risk, even when the recordings are done with the same measurement device, according to a study.
Home BP a better measure of CVD risk than office BP, says study
15 Jun 2023
Pain mechanisms tied to disease activity in DMARD-treated RA
A recent study has shown the importance of identifying and treating aberrant peripheral and central pain regulation in patients with rheumatoid arthritis (RA) who are either initiating or switching to disease-modifying antirheumatic drug (DMARD) treatment.
Pain mechanisms tied to disease activity in DMARD-treated RA
15 Jun 2023
Upfront perfusion imaging may extend thrombectomy window in acute ischaemic stroke due to LVO
Upfront perfusion imaging may extend time window for endovascular thrombectomy (EVT) beyond 24 hours in patients with acute ischaemic stroke due to large vessel occlusion (LVO-AIS), according to data presented at AIM 2023.
